摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,6-二甲基噻吩[2,3-D]嘧啶-4(3H)-酮 | 18593-44-7

中文名称
5,6-二甲基噻吩[2,3-D]嘧啶-4(3H)-酮
中文别名
5,6-二甲基噻吩并[2,3-d]嘧啶-4(3H)-酮
英文名称
5,6-dimethylthieno[2,3-d]pyrimidin-4(3H)-one
英文别名
5,6-dimethylthieno[2,3-d]pyrimidin-4-ol
5,6-二甲基噻吩[2,3-D]嘧啶-4(3H)-酮化学式
CAS
18593-44-7
化学式
C8H8N2OS
mdl
MFCD00463622
分子量
180.23
InChiKey
QAFMGDDXMIKGEY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    269-270℃ (ethanol )

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    69.7
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2934999090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H315,H319,H335
  • 储存条件:
    存储条件:2-8°C,避光干燥密闭保存。

SDS

SDS:19b4496c549c2016c324f8fc427fcf5a
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 5,6-Dimethyl-3H-thieno[2,3-d]pyrimidin-4-one
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 5,6-Dimethyl-3H-thieno[2,3-d]pyrimidin-4-one
CAS number: 18593-44-7

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H8N2OS
Molecular weight: 180.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, sulfur oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3
    • 4

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Antiproliferative Activity of Novel Thiophene and Thienopyrimidine Derivatives
    摘要:
    一种新合成的噻吩衍生物系列被制备并测试其抗增殖活性,包括乙基-4,5-二甲基-2-(3-(3,4,5-三甲氧基苯)硫脲基)噻吩-3-羧酸乙酯 3,乙基-2-[(2-(二甲氨基)乙氧基)硫代](甲烯氨基)]-4,5-二甲基噻吩-3-羧酸乙酯 9,噻吩嘧啶类化合物 4、7、10–20,三氮唑噻吩嘧啶类化合物 5、6。合成化合物的结构通过元素分析、红外光谱、1H-NMR、13C-NMR和质谱数据得到确认。结果表明,合成的化合物在乳腺癌细胞系上的活性高于结肠癌细胞系,本研究中最有效的化合物是化合物 3 和 13,对 MDA-MB-231(乳腺癌)和 HT-29(结肠癌)细胞系具有显著活性,化合物 3 的 IC50 值为 (40.68, 49.22 μM),化合物 13 的 IC50 值为 (34.04, 45.62 μM)。此外,化合物 4–6 和 9 对乳腺癌细胞系表现出中等活性,而化合物 15、19 和 20 则未显示活性。
    DOI:
    10.1055/s-0033-1358679
  • 作为产物:
    描述:
    2-氨基-4,5-二甲基噻吩-3-羧酸乙酯一水合肼溶剂黄146 、 sodium nitrite 作用下, 以 为溶剂, 反应 1.17h, 生成 5,6-二甲基噻吩[2,3-D]嘧啶-4(3H)-酮
    参考文献:
    名称:
    Gakhar, H. K.; Gill, J. K., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1985, vol. 24, p. 432 - 433
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Convenient and Efficient Synthesis of Some Novel Fused Thieno Pyrimidines Using Gewald's Reaction
    作者:Ramakrishna V. S. Nirogi、Rama Sastri Kambhampati、Prabhakar Kothmirkar、Sobhanadri Arepalli、Narasimha Reddy G. Pamuleti、Anil K. Shinde、P. K. Dubey
    DOI:10.1080/00397911.2010.515357
    日期:2011.10
    Abstract Several functionalized thienopyrimidines were synthesized by a facile synthetic method, which includes Gewald's reaction, and were characterized by spectral and analytical data. These functionalized thienopyrimidines were converted to various new chemical entities of biological importance, such as 2-piperazinymethyl thienopyrimidines (6, 8), 4-dimethylaminoethoxy thienopyrimidines (11), and
    摘要 通过Gewald反应等简便的合成方法合成了几种功能化的噻吩并嘧啶,并通过光谱和分析数据进行了表征。这些功能化的噻吩并嘧啶被转化为各种具有生物学重要性的新化学实体,例如 2-哌嗪甲基噻吩并嘧啶 (6, 8)、4-二甲氨基乙氧基噻吩并嘧啶 (11) 和 3-二甲氨基乙基噻吩并嘧啶 (12)。筛选由此合成的所有化合物的体外生物活性。一些化合物显示出有希望的血清素 5-HT6 受体拮抗剂活性。
  • Identification of 5,6-substituted 4-aminothieno[2,3-d]pyrimidines as LIMK1 inhibitors
    作者:Brad E. Sleebs、George Nikolakopoulos、Ian P. Street、Hendrik Falk、Jonathan B. Baell
    DOI:10.1016/j.bmcl.2011.07.050
    日期:2011.10
    4-Aminobenzothieno[3,2-d]pyrimidines were previously identified in a high throughput screening campaign as LIMK1 inhibitors. Scaffold reversal led to the identification of a series of simple 5,6-substituted 4-aminothieno[2,3-d]pyrimidines with low micromolar inhibition of LIMK1.
    4-氨基苯并噻吩并[3,2- d ]嘧啶先前在高通量筛选活动中被鉴定为LIMK1抑制剂。支架逆转导致鉴定了一系列简单的5,6-取代的4-氨基噻吩并[2,3- d ]嘧啶,对LIMK1的抑制作用很小。
  • Design and synthesis of novel protein kinase CK2 inhibitors on the base of 4-aminothieno[2,3-d]pyrimidines
    作者:Olga V. Ostrynska、Anatoliy O. Balanda、Volodymyr G. Bdzhola、Andriy G. Golub、Igor M. Kotey、Olexander P. Kukharenko、Andrii A. Gryshchenko、Nadiia V. Briukhovetska、Sergiy M. Yarmoluk
    DOI:10.1016/j.ejmech.2016.03.004
    日期:2016.6
    research work has resulted in a number of new ATP-competitive CK2 inhibitors that have been identified among 4-aminothieno[2,3-d]pyrimidine derivatives. The most active compounds obtained in the course of the research are 3-(5-p-tolyl-thieno[2,3-d]pyrimidin-4-ylamino)-benzoic acid, 5e (NHTP23, IC50 = 0.01 μM), 3-(5-phenyl-thieno[2,3-d]pyrimidin-4-ylamino)-benzoic acid, 5g (NHTP25, IC50 = 0.065 μM) and 3
    我们先前研究工作的扩展已导致在4-氨基噻吩并[2,3-d]嘧啶衍生物中鉴定出许多新的与ATP竞争的CK2抑制剂。在研究过程中获得的活性最高的化合物是3-(5-对甲苯基-噻吩并[2,3-d]嘧啶-4-基氨基)苯甲酸5e(NHTP23,IC 50  = 0.01μM), 3-(5-苯基-噻吩并[2,3-d]嘧啶-4-基氨基)-苯甲酸,5g(NHTP25,IC 50  = 0.065μM)和3-(6-甲基-5-苯基-噻吩并[2 ,3-d]嘧啶-4-基氨基)-苯甲酸,5n(NHTP33,IC 50 = 0.008μM)。研究了测试的4-氨基噻吩并[2,3-d]嘧啶衍生物的结构-活性关系,并提出了它们与CK2 ATP受体位点的结合方式。讨论了分子内氢键对化合物结构的负面影响。
  • Computer-aided identification, synthesis and evaluation of substituted thienopyrimidines as novel inhibitors of HCV replication
    作者:Marcella Bassetto、Pieter Leyssen、Johan Neyts、Mark M. Yerukhimovich、David N. Frick、Andrea Brancale
    DOI:10.1016/j.ejmech.2016.07.035
    日期:2016.11
    technique was applied to the study of the HCV NS3 helicase, with the aim to find novel inhibitors of the HCV replication. A library of approximately 450000 commercially available compounds was analysed in silico and 21 structures were selected for biological evaluation in the HCV replicon assay. One hit characterized by a substituted thieno-pyrimidine scaffold was found to inhibit the viral replication with
    基于结构的虚拟筛选技术已应用于HCV NS3解旋酶的研究,目的是寻找HCV复制的新型抑制剂。在计算机上分析了大约450000种可商购化合物的文库,并选择了21种结构用于HCV复制子测定的生物学评估。发现一个以取代的噻吩并嘧啶骨架为特征的命中物以亚微摩尔范围的EC 50值和良好的选择性指数抑制病毒复制。设计并合成了不同系列的新型噻吩并嘧啶衍生物。几个新结构显示出在低或亚微摩尔范围内的抗病毒活性。
  • 4-Substituted thieno[2,3-<i>d</i>]pyrimidines as potent antibacterial agents: Rational design, microwave-assisted synthesis, biological evaluation and molecular docking studies
    作者:Rupinder K. Gill、Harpreet Singh、Tilak Raj、Anuradha Sharma、Gagandeep Singh、Jitender Bariwal
    DOI:10.1111/cbdd.13028
    日期:2017.12
    4-Substituted thieno[2,3-d]pyrimidines were designed, synthesized and evaluated for antibacterial activity. Docking studies suggest the bacterial dihydropteroate synthase inhibitory activity of potent compounds. Hence, its binding affinity with DHPS enzyme was also determined.
    设计,合成4-取代的噻吩并[2,3- d ]嘧啶并评估其抗菌活性。对接研究表明,强效化合物对细菌二氢蝶呤合酶具有抑制活性。因此,还确定了其与DHPS酶的结合亲和力。
查看更多

同类化合物

林扎戈利 替普司特 噻吩并[3,4-d]嘧啶-2,4(1H,3H,5H,7H)-二酮 噻吩并[3,2-d]嘧啶-7-甲胺 噻吩并[3,2-d]嘧啶-4-羧酸 噻吩并[3,2-d]嘧啶-4(1H)-硫酮 噻吩并[3,2-d]嘧啶,4-(甲硫基)- 噻吩并[3,2-d]嘧啶 噻吩并[3,2-D]嘧啶-7-羧酸 噻吩并[3,2-D]嘧啶-7-甲醛 噻吩并[3,2-D]嘧啶-7-基甲醇 噻吩并[3,2-D]嘧啶-2-胺 噻吩并[2,3-d]嘧啶-4-胺 噻吩并[2,3-d]嘧啶-4-硫醇 噻吩并[2,3-d]嘧啶-4(3H)-酮 噻吩并[2,3-d]嘧啶-2,4-二胺 噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮,3-(3-甲氧苯基)-6-(4-甲氧苯基)-5-甲基- 噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮,3-(3-氯苯基)-1-[(2,6-二氟苯基)甲基]-6-(4-甲氧苯基)-5-甲基- 噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮,3-(2-氯苯基)-1-[(2,6-二氟苯基)甲基]-6-(4-甲氧苯基)-5-甲基- 噻吩并[2,3-d]嘧啶 噻吩并[2,3-D]嘧啶-6-羧酸 噻吩并[2,3-D]嘧啶-6-甲醛 吡啶并[3’,2’:4,5]噻吩并[3,2-d]嘧啶-4(3h)-酮 乙基3-甲基-5-羰基-5H-[1]苯并噻吩并[2,3-d][1,3]噻唑并[3,2-a]嘧啶-2-羧酸酯 乙基2-(4-氯苯基)-7-甲基-9-羰基-9H-[1,3]噻唑并[3,2-a]噻吩并[3,2-d]嘧啶-6-羧酸酯 {[((4-氧代-3,4,5,6,7,8-六氢[1]苯并噻吩并[2,3-d]嘧啶-2-基)甲基]硫基}乙酸 [(6-甲基噻吩并[2,3-d]嘧啶-4-基)硫基]乙酸 [(4-氧代-3,4,5,6,7,8-六氢[1]苯并噻吩并[2,3-d]嘧啶-2-基)硫基]乙酸 PI3K抑制剂 PF-3758309抑制剂 Necrostatin-5; 2-[[3,4,5,6,7,8-六氢-3-(4-甲氧基苯基)-4-氧代[1]苯并噻吩并[2,3-d]嘧啶-2-基]硫代]-乙腈 N-甲基-1-噻吩并[3,2-d]嘧啶-4-基-4-哌啶甲胺 N-[2-[[3,4-二氢-4-氧代-3-[4-(2,2,2-三氟乙氧基)苯基]噻吩并[3,4-d]嘧啶-2-基]硫基]乙基]乙酰胺 N-[(1S)-2-(二甲基氨基)-1-苯基乙基]-2,6-二氢-6,6-二甲基-3-[(2-甲基噻吩并[3,2-d]嘧啶-4-基)氨基]-吡咯并[3,4-c]吡唑-5(4H)-甲酰胺盐酸盐 N-(6-甲基-2-苯并噻唑基)-2-[(3,4,6,7-四氢-3-(2-甲氧基苯基)-4-氧噻吩并[3,2-d]嘧啶-2-基)硫代]-乙酰胺 N-(4-氟苯基)-5,6-二甲基噻吩并[2,3-D]嘧啶-4-胺 N-(4-吗啉-4-基噻吩并[2,3-e]嘧啶-2-基)乙烷-1,2-二胺 N,N-二甲基-5,6,7,8-四氢苯并[4,5]噻吩并[2,3-D]嘧啶-4-胺 IWP2;N-(6-甲基-2-苯并噻唑基)-2-[(3,4,6,7-四氢-4-氧代-3-苯基噻吩并[3,2d]嘧啶-2-基)硫基]乙酰胺 AR-C 155858; (S)-6-[(3,5-二甲基-1H-吡唑-4-基)甲基]-5-[(4-羟基异噁唑烷-2-基)羰基]-1-异丁基-3-甲基噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮 7-甲基噻吩并[3,2-D]嘧啶-4-胺 7-甲基-噻吩并[3,2-d]嘧啶-2,4(1h,3h)-二酮 7-甲基-噻吩并[3,2-d]嘧啶 7-甲基-5,6,7,8-四氢[1]苯并噻吩并[2,3-d]嘧啶-4(3h)-酮 7-甲基-5,6,7,8-四氢-苯并[4,5]噻吩并[2,3-d]嘧啶-4-硫醇 7-溴噻吩并[3,2-d]嘧啶 7-溴噻吩并[3,2-D]嘧啶-4(1H)-酮 7-溴-噻吩并[3,2-d]嘧啶-4-胺 7-溴-4-氯噻酚并[3,2-D]嘧啶 7-溴-2-氯噻吩并[3,2-D]嘧啶